Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 20736984)

1.

Malignancy after renal transplantation: the role of immunosuppression.

Rama I, Grinyó JM.

Nat Rev Nephrol. 2010 Sep;6(9):511-9. doi: 10.1038/nrneph.2010.102. Review.

PMID:
20736984
2.
3.

Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review.

Gutierrez-Dalmau A, Campistol JM.

Drugs. 2007;67(8):1167-98. Review.

PMID:
17521218
4.

[Pro and anti-neoplastic effects of immunosuppressive drug in renal transplantation].

Infante B, Stallone G, Schena A, Maiorano A, Gesualdo L, Schena FP, Grandaliano G.

G Ital Nefrol. 2006 Jul-Aug;23(4):389-95. Review. Italian.

PMID:
17063439
5.

Patient survival after renal transplantation; more than 25 years follow-up.

Arend SM, Mallat MJ, Westendorp RJ, van der Woude FJ, van Es LA.

Nephrol Dial Transplant. 1997 Aug;12(8):1672-9.

6.

Urological malignancy after renal transplantation.

Besarani D, Cranston D.

BJU Int. 2007 Sep;100(3):502-5. Review.

PMID:
17669141
7.

Risk factors for and management of post-transplantation cardiovascular disease.

Fellström B.

BioDrugs. 2001;15(4):261-78. Review.

PMID:
11437691
8.

Cancer incidence after immunosuppressive treatment following kidney transplantation.

Andrés A.

Crit Rev Oncol Hematol. 2005 Oct;56(1):71-85. Review.

PMID:
15978827
10.

Early diagnosis of cancer in renal transplant patients: a single center experience.

Yildirim Y, Ozyilkan O, Emiroglu R, Demirhan B, Karakayali H, Haberal M.

Asian Pac J Cancer Prev. 2006 Apr-Jun;7(2):336-9. Review.

11.

Treatment of oropharyngeal cancer in renal transplant recipients without cessation of immunosuppressive therapy.

Singh SK, Gupta AK, Jha V, Kohli HS, Gupta KL, Minz M, Sakhuja V.

Transplant Proc. 2006 Sep;38(7):2088-9.

PMID:
16980008
12.

Risk of malignancy with long-term immunosuppression in renal transplant recipients.

Agraharkar ML, Cinclair RD, Kuo YF, Daller JA, Shahinian VB.

Kidney Int. 2004 Jul;66(1):383-9.

PMID:
15200447
13.

Clinical insights for cancer outcomes in renal transplant patients.

Alberú J.

Transplant Proc. 2010 Nov;42(9 Suppl):S36-40. doi: 10.1016/j.transproceed.2010.07.006. Review.

PMID:
21095450
14.

[Skin cancer in renal transplant recipients].

Mangino M, Schena FP.

G Ital Nefrol. 2010 Sep-Oct;27 Suppl 50:S75-80. Italian.

PMID:
20922700
15.

The janus face of immunosuppression - de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich.

Wimmer CD, Rentsch M, Crispin A, Illner WD, Arbogast H, Graeb C, Jauch KW, Guba M.

Kidney Int. 2007 Jun;71(12):1271-8. Epub 2007 Feb 28.

PMID:
17332737
16.

Malignancy following renal transplantation.

Yang TC, Shu KH, Cheng CH, Wu MJ, Lian JD.

Zhonghua Yi Xue Za Zhi (Taipei). 1998 May;61(5):281-8.

PMID:
9650432
17.

Malignancies in renal transplantation: an unmet medical need.

Dantal J, Pohanka E.

Nephrol Dial Transplant. 2007 May;22 Suppl 1:i4-10. Review.

18.

Cancers after renal transplantation.

Wong G, Chapman JR.

Transplant Rev (Orlando). 2008 Apr;22(2):141-9. doi: 10.1016/j.trre.2007.12.004. Review.

PMID:
18631867
19.

Malignancy after renal transplantation: incidence and role of type of immunosuppression.

Tremblay F, Fernandes M, Habbab F, deB Edwardes MD, Loertscher R, Meterissian S.

Ann Surg Oncol. 2002 Oct;9(8):785-8.

PMID:
12374662
20.

Malignancy in kidney transplant recipients.

Kapoor A.

Drugs. 2008;68 Suppl 1:11-9. Review.

PMID:
18442297
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk